H.R. 4215 · 115th Congress

To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.

Stage
In committee
Introduced
2017-11-01
Latest action
2017-11-01 · Introduced in House

Cosponsors (26)

Tom Emmer